financing

News

Boundless Bio raises $100m for circular DNA cancer therapy

Boundless Bio’s plans to develop a new class of cancer therapies targeting DNA found outside the nucleus of malignant cells have been boosted by a $100 million fundraising

News

J&J sets top price for consumer health unit Kenvue’s IPO

Johnson & Johnson’s consumer health unit Kenvue looks set to raise $3.8 billion in an upsized initial public offering (IPO), valuing the business at around $41 billion

News

Last year’s UK biotech financing dip extends into 2023

The first quarter of 2023 saw just £295 million raised by UK-based life sciences and biotech companies, signalling that investor confidence remains low after a disappointi

News

Arcadia’s $125m debt vehicle heads digital funding roundup

Investor sentiment for companies operating in the digital health category is likely to be somewhat shaken by the bankruptcy of pioneer

News

Complement raises €72m for geographic atrophy gene therapy

UK start-up Complement Therapeutics has raised an impressive €72 million ($79 million) in first-round financing that will be used to take a gene therapy for sight-robbing

News

More claudin buzz as Alentis raises $105m

Swiss biotech Alentis Therapeutics has raised a very respectable $105 million in third-round financing that will be dedicated to the development of its Claudin-targeting d

Boundless Bio raises $100m for circular DNA cancer therapy

J&J sets top price for consumer health unit Kenvue’s IPO

Last year’s UK biotech financing dip extends into 2023

Arcadia’s $125m debt vehicle heads digital funding roundup

Complement raises €72m for geographic atrophy gene therapy

More claudin buzz as Alentis raises $105m

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

financing

Editor's Picks